Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 5 pseudogene 1 (CCT5P1) is classified as a **pseudogene** and does not encode a functional protein product[7][5][2][1]. It is related to the *CCT5* gene, which is part of the chaperonin containing TCP1 complex (TRiC), a molecular chaperone involved in ATP-dependent protein folding such as actin and tubulin[4][13]. However, *CCT5P1* itself is not functionally active and is not considered a therapeutic target, receptor, enzyme, transporter, or biomarker[7][5]. The term “pseudogene” indicates that it is a genomic DNA sequence similar to a gene but nonfunctional, generally due to mutations or truncations. **Notes:** - *CCT5P1* should not be confused with the functional chaperone protein *CCT5* or the larger chaperonin TCP1 complex. Information for *CCT5* or related pseudogenes (e.g., CCT5P2) should not be used in place of details for *CCT5P1* specifically[7][5][4]. - No evidence suggests *CCT5P1* is involved in disease, biological functions, or is targeted by drugs[7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 5 pseudogene 1 (CCT5P1).